全文获取类型
收费全文 | 2254篇 |
免费 | 209篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 85篇 |
妇产科学 | 60篇 |
基础医学 | 341篇 |
口腔科学 | 34篇 |
临床医学 | 241篇 |
内科学 | 549篇 |
皮肤病学 | 47篇 |
神经病学 | 115篇 |
特种医学 | 130篇 |
外科学 | 331篇 |
综合类 | 54篇 |
一般理论 | 3篇 |
预防医学 | 121篇 |
眼科学 | 55篇 |
药学 | 138篇 |
中国医学 | 5篇 |
肿瘤学 | 148篇 |
出版年
2023年 | 25篇 |
2022年 | 16篇 |
2021年 | 47篇 |
2020年 | 37篇 |
2019年 | 53篇 |
2018年 | 57篇 |
2017年 | 39篇 |
2016年 | 45篇 |
2015年 | 46篇 |
2014年 | 68篇 |
2013年 | 95篇 |
2012年 | 130篇 |
2011年 | 123篇 |
2010年 | 77篇 |
2009年 | 89篇 |
2008年 | 101篇 |
2007年 | 105篇 |
2006年 | 106篇 |
2005年 | 104篇 |
2004年 | 83篇 |
2003年 | 79篇 |
2002年 | 96篇 |
2001年 | 25篇 |
1999年 | 24篇 |
1998年 | 36篇 |
1997年 | 56篇 |
1996年 | 43篇 |
1995年 | 35篇 |
1994年 | 33篇 |
1993年 | 37篇 |
1992年 | 23篇 |
1991年 | 21篇 |
1990年 | 13篇 |
1989年 | 36篇 |
1988年 | 22篇 |
1987年 | 16篇 |
1986年 | 23篇 |
1985年 | 25篇 |
1984年 | 23篇 |
1983年 | 16篇 |
1982年 | 15篇 |
1981年 | 29篇 |
1980年 | 19篇 |
1979年 | 13篇 |
1978年 | 24篇 |
1977年 | 30篇 |
1976年 | 20篇 |
1975年 | 13篇 |
1974年 | 15篇 |
1962年 | 19篇 |
排序方式: 共有2468条查询结果,搜索用时 15 毫秒
1.
V Aerra M Kuduvalli AN Moloto AK Srinivasan AD Grayson BM Fabri AY Oo 《Journal of cardiothoracic surgery》2006,1(1):6-5
Background
Atrial fibrillation can occur in up to 40% of patients undergoing coronary surgery. 相似文献2.
3.
The effect of the barbiturate T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid; DMMDPB) on essential tremor, given in twice daily doses of 400 and 300 mg, was assessed in two brief, randomized, placebo-controlled, parallel-group, double-blinded, single-center trials in 12 and 22 patients, respectively. These trials represent the first clinical use of T2000 for a specific indication. The primary endpoint was the change in the mean scores of the treated and control groups based on the Fahn-Tolosa-Marin tremor scale. In the first study of 12 patients treated with 400 mg or placebo twice daily for 14 days, the mean change from baseline at day 14 was 19.3 (P < 0.0001) in the treated group and 9.0 (P = 0.0121) in the control group. Using a two-factor mixed ANOVA model to evaluate within group and between group changes, the effect of T2000 was significantly different from that of the placebo group (P = 0.03). In the second study of 22 patients treated with 300 mg of T2000 or placebo twice daily for 20 days, statistically significant changes were seen in treated patients compared to baseline, but the ANOVA model did not demonstrate a significant treatment effect of T2000 compared to placebo. When the treated groups from each study are compared, the 800-mg daily group is significantly different from the 600-mg daily group (P = 0.02). Some treated patients in each study, but no placebo patients, experienced marked improvement. These results support further evaluation of T2000 in the treatment of essential tremor. 相似文献
4.
目的由于卒中风险随着狭窄严重程度的增加而升高,因此认为颈内动脉(ICA)接近闭塞患者的卒中风险很高。在现有的随机试验中,还没有专门针对这种情况进行探讨,因此其处理尚存在争汶。方法:对相关文献进行系统评价。结果:对ICA接近闭塞患者的处理还存在争议:一些学者支持进行干预,而另一些学者则认为存在风险或没有益处而反对进行干预。在ICA接近闭塞的有症状患者中进行一项比较外科治疗与最佳内科治疗的多中心前瞻性随机试验似乎非常困难,因为这类研究需要大量的患者。尽管如此,基于目前的证据,似乎很难拒绝手术治疗。结论:由于目前对ICA接近闭塞患者的最佳处理方案仍存在着争议,因此需要前瞻性观察性研究以证实其在有症状和无症状人群中的患病率以及相关的卒中风险。基于目前的证据,大多数医疗中心选择手术治疗,但它相对干内科治疗的特粱尚右待证章. 相似文献
5.
6.
7.
Balwantray C. Chauhan Stephen M. Drance Calvin Lai 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》1989,227(3):216-220
Cluster analysis in perimetry is a technique used in the evaluation of localised visual field loss. It has previously been applied to suprathreshold data and, unlike the indices currently available to indicate localised loss, it is influenced by the relative positions of individual defects. This paper describes a cluster analysis for use with data from Program 31 of the Octopus perimeter. To demonstrate the technique, sensitivity values of normal 60-year-old subject were altered to simulate localised loss. Illustrative examples of clinical cases are given, showing differing degrees of localised loss that do not influence the corrected loss variance (CLV) but influence the computed cluster parameters. It is hoped that the value of this form of analysis will be demonstrated in clinical follow-up of glaucoma patients. 相似文献
8.
Robert A. Schnoll Ph.D. James Calvin B.A. Michael Malstrom B.S. Randi L. Rothman B.A. Hao Wang M.S. James Babb Ph.D. Suzanne M. Miller Ph.D. John A. Ridge M.D. Ph.D. Benjamin Movsas M.D. Corey Langer M.D. Michael Unger M.D. Melvyn Goldberg M.D. 《Annals of behavioral medicine》2003,25(3):214-221
Even though continued smoking by cancer patients adversely affects survival and quality of life, about one third of patients
who smoked prior to their diagnosis continue to smoke after their diagnosis. The implementation of smoking cessation treatments
for cancer patients has been slowed by the lack of data on correlates of tobacco use in this population. Thus, this longitudinal
study assessed demographic, medical, addiction, and psychological predictors of tobacco use among 74 head, neck, and lung
cancer patients. Multivariable binary logistic regression analyses, with outcome categorized as smoker or nonsmoker, indicated
that the likelihoodthat patients would be a smoker was associated with lower levels of perceived risk and a higher level of
quitting cons. Multivariable nominal logistic regression, with outcome classified as continuous smoker, continuous quitter,
relapser, or follow-up quitter, indicated that: (a) patients categorized as continuous smokers reported significantly lower
quitting self-efficacy than follow-up quitters and continuous quitters, (b) relapsers reported a significantly lower level
of quitting self-efficacy than either follow-up quitters or continuous quitters, and (c) continuous smokers exhibited a significantly
lower level of risk perceptions than continuous abstainers. These findings can be useful for the development and evaluation
of treatments to promote smoking cessation among cancer patients.
Support for this study was provided by National Institutes of Health Grants CA57708, CA06927, CA88610, CA95678, and CA76644. 相似文献
9.
R Zachariah AD Harries MP Spielmann V Arendt D Nchingula R Mwenda O Courtielle P Kirpach B Mwale FML Salaniponi 《Malawi medical journal : the journal of Medical Association of Malawi》2002,14(2):10-12
In Thyolo district, Malawi, an operational research study is being conducted on the efficacy and feasibility of co-trimoxazole prophylaxis in preventing deaths in HIV-positive patients with tuberculosis (TB). A series of cross-sectional studies were carried out to determine i) whether faecal Escherichia coli (E.coli) resistance to co-trimoxazole in TB patients changed with time and ii) whether the resistance pattern was different in HIV positive TB patients who were taking co-trimoxazole prophylaxis. Co-trimoxazole resistance among E.coli isolates in TB patients at the time of registration was 60% in 1999 and 77% in 2001 (p<0.01). Resistance was 89% among HIV-infected TB patients (receiving co-trimoxazole), while in HIV negative patients (receiving anti-TB therapy alone) it was 62% (p<0.001). The study shows a significant increase of E.coli resistance to co-trimoxazole in TB patients which is particularly prominent in HIV infected patients on co-trimoxazole prophylaxis. Since a high degree of plasmid-mediated transfer of resistance exists between E.coli and the Salmonella species, these findings could herald limitations on the short and long term benefits to be anticipated from the use of co-trimoxazole prophylaxis in preventing non-typhoidal salmonella bacteraemia and enteritis in HIV infected TB patients in Malawi. 相似文献
10.
A recombinant bisphosphoglycerate mutase variant with acid phosphatase homology degrades 2,3-diphosphoglycerate. 下载免费PDF全文
M C Garel N Arous M C Calvin C T Craescu J Rosa R Rosa 《Proceedings of the National Academy of Sciences of the United States of America》1994,91(9):3593-3597
To date no definite and undisputed treatment has been found for sickle cell anemia, which is characterized by polymerization of a deoxygenated hemoglobin mutant (HbS) giving rise to deformed erythrocytes and vasoocclusive complications. Since the erythrocyte glycerate 2,3-bisphosphate (2,3-DPG) has been shown to facilitate this polymerization, one therapeutic approach would be to decrease the intraerythrocytic level of 2,3-DPG by increasing the phosphatase activity of the bisphosphoglycerate mutase (BPGM; 3-phospho-D-glycerate 1,2-phosphomutase, EC 5.4.2.4). For this purpose, we have investigated the role of Gly-13, which is located in the active site sequence Arg9-His10-Gly11-Glu12-Gly13 in human BPGM. This sequence is similar to the Arg-His-Gly-Xaa-Arg* sequence of the distantly related acid phosphatases, which catalyze as BPGM similar phosphoryl transfers but to a greater extent. We hypothesized that the conserved Arg* residue in acid phosphatase sequences facilitates the phosphoryl transfer. Consequently, in human BPGM, we replaced by site-directed mutagenesis the corresponding amino acid residue Gly13 with an Arg or a Lys. In another experiment, we replaced Gly13 with Ser, the amino acid present at the corresponding position of the homologous yeast phosphoglycerate mutase (D-phosphoglycerate 2,3-phosphomutase, EC 5.4.2.1). Mutation of Gly13 to Ser did not modify the synthase activity, whereas the mutase and the phosphatase were 2-fold increased or decreased, respectively. However, replacing Gly13 with Arg enhanced phosphatase activity 28.6-fold, whereas synthase and mutase activities were 10-fold decreased. The presence of a Lys in position 13 gave rise to a smaller increase in phosphatase activity (6.5-fold) but an identical decrease in synthase and mutase activities. Taken together these results support the hypothesis that a positively charged amino acid residue in position 13, especially Arg, greatly activates the phosphoryl transfer to water. These results also provide elements for locating the conserved Arg* residue in the active site of acid phosphatases and facilitating the phosphoryl transfer. The implications for genetic therapy of sickle cell disease are discussed. 相似文献